A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients

OBJECTIVES: Despite recent advances in the treatment of advanced ovarian cancer, drug selection after second-line chemotherapy has not been well studied. In this study, we retrospectively evaluated the effect and safety of apatinib as monotherapy or in combination with chemotherapy for the treatment...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Manag Res
Main Authors: Yang, Mi, Liu, Xiufeng, Zhang, Cheng, Liao, Feng, Li, Zixiong, Luo, Xianwen, Sun, Yiran, Chen, Chao
Format: Artigo
Language:Inglês
Published: Dove 2019
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790407/
https://ncbi.nlm.nih.gov/pubmed/31632146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S223372
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items